Experience

Bioprojet

• France
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Chief Scientific Officer, Head of Research

  • Mar 2020 - Present

  Paris, Rennes Lead research activities (chemistry, biology, pharmacology, ADME/PK and IND-enabling studies) at Bioprojet Biotech. Main therapeutic areas of interest are CNS and Immunology Coordinate scientific activities at group level



Sanofi

• France
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Global Head of Cardiovascular and Metabolism Business Development and Licensing

  • Jan 2017 - Feb 2020

  Paris Lead all in-licensing and out-licensing activities (scouting, evaluation, transaction) in the CVM domain

• Head of Strategic Projects

  • Dec 2014 - Dec 2016

  Paris Lead R&D and Corporate Strategic Projects (pharma R&D, vaccine R&D, animal health)

• Scientific Director, Toulouse R&D site

  • Sep 2011 - Dec 2014

  Toulouse Lead internal and external scientific strategy and operations of the Toulouse R&D site (650 associates)

• Global Head of Discovery External Innovation

  • Jan 2008 - Aug 2011

  Montpellier Implement and Coordinate Discovery External Innovation (scouting, scientific and business evaluation, due diligence) Set up a strong scientific (academic and biotech) network in US and Europe Lead Discovery Portfolio Review

• Global Head of Exploratory Research Department

  • 2001 - 2008

  Montpellier Operationnal management (220 + scientists, medicinal chemistry, in vitro and in vivo biology, screening, hit to lead and lead optimization phases) - Lead multi-sites operations ( France, Germany, Italy

• Head of Research Department - Chinoin R&D

  • Oct 1998 - Sep 2001

  Budapest, Hungary Lead all research activities from target validation to development candiate nomination in Inflammation, Immunology and Respiratory domains

• Head of Pharmacology Unit - Cardiovascular R&D Department

  • Sep 1994 - Oct 1998

  Montpellier Manage a team of 15 researchers (in vitro and in vivo cardiovascular pharmacology Lead a development project (Dronedarone - new anti-arhythmic agent)

• Head of Laboratory - Cardiovascular R&D Department

  • Jan 1992 - Aug 1994

  Brussels Manage a team of 5 researchers (in vivo cardiovascular department) Develop new pharmacological models in both small and large animals Support new anti-arythmic agents characterization